Cite
Iwase T, Katada E, Matsukawa N, et al. High levels of hippocampal cholinergic neurostimulating peptide (HCNP) in the CSF of some patients with Alzheimer's disease. Eur J Neurol. 1998;5(6):561-569doi: 10.1046/j.1468-1331.1998.560561.x.
Iwase, T., Katada, E., Matsukawa, N., Mitake, S., Ojika, K., Otsuka, Y., & Tsugu, Y. (1998). High levels of hippocampal cholinergic neurostimulating peptide (HCNP) in the CSF of some patients with Alzheimer's disease. European journal of neurology, 5(6), 561-569. https://doi.org/10.1046/j.1468-1331.1998.560561.x
Iwase, et al. "High levels of hippocampal cholinergic neurostimulating peptide (HCNP) in the CSF of some patients with Alzheimer's disease." European journal of neurology vol. 5,6 (1998): 561-569. doi: https://doi.org/10.1046/j.1468-1331.1998.560561.x
Iwase T, Katada E, Matsukawa N, Mitake S, Ojika K, Otsuka Y, Tsugu Y. High levels of hippocampal cholinergic neurostimulating peptide (HCNP) in the CSF of some patients with Alzheimer's disease. Eur J Neurol. 1998 Nov;5(6):561-569. doi: 10.1046/j.1468-1331.1998.560561.x. PMID: 10210891.
Copy
Download .nbib